[1] |
黄勋, 吴安华. 脓毒症诊断标准变迁及热点问题探讨[J]. 中国感染控制杂志, 2019, 18(6):461-464.
|
[2] |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock(Sepsis-3)[J]. JAMA, 2016, 315(8):801-810.
DOI
URL
|
[3] |
STERLING S A, PUSKARICH M A, GLASS A F, et al. The impact of the Sepsis-3 septic shock definition on previously defined septic shock patients[J]. Crit Care Med, 2017, 45(9):1436-1442.
DOI
URL
|
[4] |
降钙素原急诊临床应用专家共识组. 降钙素原(PCT)急诊临床应用的专家共识[J]. 中华急诊医学杂志, 2012, 21(9):944-951.
|
[5] |
CHIVATE C G, BELWALKAR G J, LIMAYE R P, et al. Procalcitonin as a marker for the diagnosis of sepsis[J]. International Journal of Research in Medical Sciences, 2016, 4(4):1216-1218.
|
[6] |
中国医药教育协会感染疾病专业委员会. 感染相关生物标志物临床意义解读专家共识[J]. 中华结核和呼吸杂志, 2017, 40(4):243-257.
|
[7] |
陈晓洁, 董天皞, 张桂萍, 等. 脓毒症定义和诊断标准的演进[J]. 医学综述, 2017, 23(16):3230-3235.
|
[8] |
KIM S J, HWANG S O, KIM Y W, et al. Procalcitonin as a diagnostic marker for sepsis/septic shock in the emergency department;a study based on Sepsis-3 definition[J]. Am J Emerg Med, 2019, 37(2):272-276.
DOI
URL
|
[9] |
SONG J, PKARK D W, MOON S, et al. Diagnostic and prognostic value of interleukin-6,pentraxin 3,and procalcitonin levels among sepsis and septic shock patients:a prospective controlled study according to the Sepsis-3 definitions[J]. BMC Infect Dis, 2019, 19(1):968.
DOI
URL
|
[10] |
ZHOU X Y, LIU Z, HUANG J, et al. Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein:a prospective cohort study in China[J]. BMJ Open, 2019, 9(4):e026527.
DOI
URL
|
[11] |
JEKARL D W, LEE S, KIM M, et al. Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3[J]. J Clin Lab Anal, 2019, 33(9):e22996.
|
[12] |
VAN OERS J A H, DE JONG E, KEMPERMAN H, et al. Diagnostic accuracy of procalcitonin and C-reactive protein is insufficient to predict proven infection:a retrospective cohort study in critically ill patients fulfilling the Sepsis-3 criteria[J]. J Appl Lab Med, 2020, 5(1):62-72.
DOI
URL
|
[13] |
DIPALO M, GUIDO L, MICCA G, et al. Multicenter comparison of automated procalcitonin immunoassays[J]. Pract Lab Med, 2015, 2:22-28.
|
[14] |
CHAMBLISS A B, HAYDEN J, COLBY J M. Evaluation of procalcitonin immunoassay concordance near clinical decision points[J]. Clin Chem Lab Med, 2019, 57(9):1414-1421.
DOI
URL
|
[15] |
LIPPI G, SALVAGNO G L, GELATI M, et al. Two-center comparison of 10 fully-automated commercial procalcitonin(PCT) immunoassays[J]. Clin Chem Lab Med, 2019, 58(1):77-84.
DOI
URL
|
[16] |
潘锡龙, 彭明, 陈燕辉, 等. 不同降钙素原检测系统的偏倚分析和一致性评价[J]. 临床检验杂志, 2020, 38(2):150-153.
|